X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Strides Arcolab - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs STRIDES SHASUN LTD - Comparison Results

STRIDES SHASUN LTD 
   Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE STRIDES SHASUN LTD TTK HEALTHCARE/
STRIDES SHASUN LTD
 
P/E (TTM) x 33.7 15.2 221.4% View Chart
P/BV x 6.2 1.8 351.9% View Chart
Dividend Yield % 0.5 0.6 83.4%  

Financials

 TTK HEALTHCARE   STRIDES SHASUN LTD
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
STRIDES SHASUN LTD
Mar-17
TTK HEALTHCARE/
STRIDES SHASUN LTD
5-Yr Chart
Click to enlarge
High Rs6631,275 52.0%   
Low Rs399918 43.5%   
Sales per share (Unadj.) Rs535.6389.6 137.5%  
Earnings per share (Unadj.) Rs15.928.0 57.0%  
Cash flow per share (Unadj.) Rs20.048.9 41.0%  
Dividends per share (Unadj.) Rs4.004.50 88.9%  
Dividend yield (eoy) %0.80.4 183.5%  
Book value per share (Unadj.) Rs137.6303.1 45.4%  
Shares outstanding (eoy) m7.7789.42 8.7%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x1.02.8 35.2%   
Avg P/E ratio x33.339.2 85.0%  
P/CF ratio (eoy) x26.522.4 118.3%  
Price / Book Value ratio x3.93.6 106.7%  
Dividend payout %25.116.1 155.9%   
Avg Mkt Cap Rs m4,12798,036 4.2%   
No. of employees `0001.75.8 29.4%   
Total wages/salary Rs m6075,881 10.3%   
Avg. sales/employee Rs Th2,436.76,005.9 40.6%   
Avg. wages/employee Rs Th355.21,014.0 35.0%   
Avg. net profit/employee Rs Th72.5431.2 16.8%   
INCOME DATA
Net Sales Rs m4,16234,834 11.9%  
Other income Rs m611,686 3.6%   
Total revenues Rs m4,22336,520 11.6%   
Gross profit Rs m1976,428 3.1%  
Depreciation Rs m321,872 1.7%   
Interest Rs m302,269 1.3%   
Profit before tax Rs m1973,973 5.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m04 0.0%   
Extraordinary Inc (Exp) Rs m0-1,006 0.0%   
Tax Rs m73470 15.5%   
Profit after tax Rs m1242,501 5.0%  
Gross profit margin %4.718.5 25.7%  
Effective tax rate %37.011.8 312.9%   
Net profit margin %3.07.2 41.5%  
BALANCE SHEET DATA
Current assets Rs m1,62938,165 4.3%   
Current liabilities Rs m1,05830,402 3.5%   
Net working cap to sales %13.722.3 61.6%  
Current ratio x1.51.3 122.7%  
Inventory Days Days3077 38.5%  
Debtors Days Days34104 32.2%  
Net fixed assets Rs m55637,639 1.5%   
Share capital Rs m78894 8.7%   
"Free" reserves Rs m87826,210 3.4%   
Net worth Rs m1,06927,105 3.9%   
Long term debt Rs m15916,377 1.0%   
Total assets Rs m2,39981,168 3.0%  
Interest coverage x7.62.8 275.5%   
Debt to equity ratio x0.10.6 24.6%  
Sales to assets ratio x1.70.4 404.2%   
Return on assets %6.45.9 109.1%  
Return on equity %11.69.2 125.6%  
Return on capital %18.512.1 153.1%  
Exports to sales %0.80-   
Imports to sales %1.40-   
Exports (fob) Rs m33NA-   
Imports (cif) Rs m58NA-   
Fx inflow Rs m3313,465 0.2%   
Fx outflow Rs m634,076 1.6%   
Net fx Rs m-309,389 -0.3%   
CASH FLOW
From Operations Rs m1272,881 4.4%  
From Investments Rs m-146-7,051 2.1%  
From Financial Activity Rs m223,382 0.6%  
Net Cashflow Rs m3-788 -0.3%  

Share Holding

Indian Promoters % 65.4 27.7 236.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 37.8 9.8%  
FIIs % 5.2 8.6 60.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 25.9 99.6%  
Shareholders   12,723 56,241 22.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   DR. REDDYS LAB  STERLING BIOTECH  ASTRAZENECA PHARMA  AUROBINDO PHARMA  IPCA LABS  

Compare TTK HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Idea Plunges 5% on Weak Q3 Peformance(Closing)

Indian share markets finished on a flat note after a five-session record-setting spree as profit booking was witnessed in metal stocks, capital goods stocks.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

'Smart Money' Enters Bitcoin. Will You?(Smart Contrarian)

Jan 17, 2018

As institutional money enters bitcoin, the gains over the last year could just be the tip of the iceberg.

Increasing Divergence Between Bond Yields and Earnings Yield(Chart Of The Day)

Jan 11, 2018

Over the past couple of months, bond yields have risen, but earning yields have fallen, increasing divergence.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Jan 24, 2018 03:33 PM

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS